Cas no 1140029-11-3 (tert-butyl 2,4-dioxo-3-oxa-9-azaspiro5.5undecane-9-carboxylate)
tert-butyl 2,4-dioxo-3-oxa-9-azaspiro5.5undecane-9-carboxylate Chemical and Physical Properties
Names and Identifiers
-
- 3-Oxa-9-azaspiro[5.5]undecane-9-carboxylic acid, 2,4-dioxo-, 1,1-diMethylethyl ester
- 2,4-dioxo-3-Oxa-9-azaspiro[5.5]undecane-9-carboxylic acid 1,1-dimethylethyl ester
- 2-Methyl-2-propanyl 2,4-dioxo-3-oxa-9-azaspiro[5.5]undecane-9-car boxylate
- tert-butyl 2,4-dioxo-3-oxa-9-azaspiro5.5undecane-9-carboxylate
-
- Inchi: InChI=1S/C14H21NO5/c1-13(2,3)20-12(18)15-6-4-14(5-7-15)8-10(16)19-11(17)9-14/h4-9H2,1-3H3
- InChI Key: VBTTVJHJPZBNRY-UHFFFAOYSA-N
- SMILES: CC(C)(C)OC(=O)N1CCC2(CC1)CC(=O)OC(=O)C2
Computed Properties
- Hydrogen Bond Donor Count: 0
- Hydrogen Bond Acceptor Count: 6
- Heavy Atom Count: 20
- Rotatable Bond Count: 3
tert-butyl 2,4-dioxo-3-oxa-9-azaspiro5.5undecane-9-carboxylate Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| Enamine | EN300-12446595-50mg |
tert-butyl 2,4-dioxo-3-oxa-9-azaspiro[5.5]undecane-9-carboxylate |
1140029-11-3 | 95.0% | 50mg |
$252.0 | 2023-10-02 | |
| Enamine | EN300-12446595-100mg |
tert-butyl 2,4-dioxo-3-oxa-9-azaspiro[5.5]undecane-9-carboxylate |
1140029-11-3 | 95.0% | 100mg |
$376.0 | 2023-10-02 | |
| Enamine | EN300-12446595-250mg |
tert-butyl 2,4-dioxo-3-oxa-9-azaspiro[5.5]undecane-9-carboxylate |
1140029-11-3 | 95.0% | 250mg |
$538.0 | 2023-10-02 | |
| Enamine | EN300-12446595-500mg |
tert-butyl 2,4-dioxo-3-oxa-9-azaspiro[5.5]undecane-9-carboxylate |
1140029-11-3 | 95.0% | 500mg |
$847.0 | 2023-10-02 | |
| Enamine | EN300-12446595-1000mg |
tert-butyl 2,4-dioxo-3-oxa-9-azaspiro[5.5]undecane-9-carboxylate |
1140029-11-3 | 95.0% | 1000mg |
$1086.0 | 2023-10-02 | |
| Enamine | EN300-12446595-2500mg |
tert-butyl 2,4-dioxo-3-oxa-9-azaspiro[5.5]undecane-9-carboxylate |
1140029-11-3 | 95.0% | 2500mg |
$2127.0 | 2023-10-02 | |
| Enamine | EN300-12446595-5000mg |
tert-butyl 2,4-dioxo-3-oxa-9-azaspiro[5.5]undecane-9-carboxylate |
1140029-11-3 | 95.0% | 5000mg |
$3147.0 | 2023-10-02 | |
| Enamine | EN300-12446595-10000mg |
tert-butyl 2,4-dioxo-3-oxa-9-azaspiro[5.5]undecane-9-carboxylate |
1140029-11-3 | 95.0% | 10000mg |
$4667.0 | 2023-10-02 | |
| Enamine | EN300-12446595-0.05g |
tert-butyl 2,4-dioxo-3-oxa-9-azaspiro[5.5]undecane-9-carboxylate |
1140029-11-3 | 95% | 0.05g |
$252.0 | 2023-05-26 | |
| Enamine | EN300-12446595-0.1g |
tert-butyl 2,4-dioxo-3-oxa-9-azaspiro[5.5]undecane-9-carboxylate |
1140029-11-3 | 95% | 0.1g |
$376.0 | 2023-05-26 |
tert-butyl 2,4-dioxo-3-oxa-9-azaspiro5.5undecane-9-carboxylate Related Literature
-
Long Deng,Qian Zou,Biao Liu,Wenhui Ye,Chengfei Zhuo,Li Chen,Ze-Yuan Deng,Ya-Wei Fan,Jing Li Food Funct., 2018,9, 4234-4245
-
Albertus D. Handoko,Khoong Hong Khoo,Teck Leong Tan,Hongmei Jin,Zhi Wei Seh J. Mater. Chem. A, 2018,6, 21885-21890
-
Ivor Lon?ari? Phys. Chem. Chem. Phys., 2015,17, 9436-9445
-
Partha Laskar,Christine Dufès Nanoscale Adv., 2021,3, 6007-6026
-
M. Zeiger,N. J?ckel,P. Strubel,L. Borchardt,R. Reinhold,W. Nickel,J. Eckert,V. Presser,S. Kaskel J. Mater. Chem. A, 2015,3, 17983-17990
Additional information on tert-butyl 2,4-dioxo-3-oxa-9-azaspiro5.5undecane-9-carboxylate
Comprehensive Overview of tert-butyl 2,4-dioxo-3-oxa-9-azaspiro[5.5]undecane-9-carboxylate (CAS No. 1140029-11-3)
The compound tert-butyl 2,4-dioxo-3-oxa-9-azaspiro[5.5]undecane-9-carboxylate (CAS No. 1140029-11-3) is a highly specialized spirocyclic derivative with significant applications in pharmaceutical research and organic synthesis. Its unique molecular structure, featuring a spiro[5.5]undecane core, makes it a valuable intermediate for designing bioactive molecules. Researchers and chemists are increasingly interested in this compound due to its potential role in developing new therapeutic agents, particularly in the fields of central nervous system (CNS) disorders and metabolic diseases.
One of the key reasons for the growing attention on tert-butyl 2,4-dioxo-3-oxa-9-azaspiro[5.5]undecane-9-carboxylate is its versatility in medicinal chemistry. The presence of both carboxylate and spirocyclic functionalities allows for diverse chemical modifications, enabling the creation of novel drug candidates. Recent studies have highlighted its utility in peptide mimetics and enzyme inhibitors, aligning with the current trend of targeting protein-protein interactions in drug discovery. This compound is also being explored for its potential in sustainable chemistry, as researchers seek eco-friendly synthetic routes for complex molecules.
In the context of synthetic methodology, CAS No. 1140029-11-3 serves as a critical building block for constructing heterocyclic frameworks. Its spirocyclic architecture is particularly appealing for designing conformationally restricted analogs, which are often more selective and potent in biological systems. The tert-butyl group in the molecule enhances its stability, making it suitable for multi-step synthesis and storage. These properties are highly relevant to the pharmaceutical industry's demand for robust intermediates that can streamline drug development pipelines.
Another area where tert-butyl 2,4-dioxo-3-oxa-9-azaspiro[5.5]undecane-9-carboxylate is gaining traction is in academic research. Universities and research institutions are investigating its role in catalysis and material science, leveraging its unique steric and electronic properties. For instance, its application in asymmetric synthesis has been explored to achieve chiral induction, a hot topic in modern organic chemistry. Additionally, its potential use in polymeric materials has sparked interest due to the rising demand for high-performance polymers in industries like electronics and biomedical engineering.
From a commercial perspective, the demand for CAS No. 1140029-11-3 is expected to rise, driven by its applicability in high-value chemical synthesis. Suppliers and manufacturers are focusing on scalable production methods to meet the needs of pharmaceutical companies and research laboratories. Quality control and regulatory compliance are also critical factors, as the compound must adhere to stringent GMP standards for use in preclinical studies. This aligns with the broader industry shift toward precision chemistry and custom synthesis services.
In summary, tert-butyl 2,4-dioxo-3-oxa-9-azaspiro[5.5]undecane-9-carboxylate (CAS No. 1140029-11-3) is a multifaceted compound with broad implications in drug discovery, material science, and sustainable chemistry. Its spirocyclic design and functional group diversity make it a standout candidate for addressing contemporary challenges in chemical research. As the scientific community continues to uncover its potential, this compound is poised to play a pivotal role in advancing innovative technologies and therapeutic solutions.
1140029-11-3 (tert-butyl 2,4-dioxo-3-oxa-9-azaspiro5.5undecane-9-carboxylate) Related Products
- 175213-46-4(tert-butyl 4-(2-methoxy-2-oxo-ethyl)piperidine-1-carboxylate)
- 154375-43-6(N-Boc-4-piperidinepropionic acid)
- 162504-75-8(1-1,1-Dimethylethoxy)\u200bcarbonyl\u200b-\u200b4-piperidinepropanoic Acid Methyl Ester)
- 124443-68-1(1-tert-Butyl 4-methyl piperidine-1,4-dicarboxylate)
- 157688-46-5(2-(1-tert-butoxycarbonyl-4-piperidyl)acetic acid)
- 135716-09-5(Tert-butyl 4-(2-ethoxy-2-oxoethyl)piperidine-1-carboxylate)
- 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
- 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
- 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
- 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)